VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Bio-Rad Laboratories, Inc. vs Manhattan Associates, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Bio-Rad Laboratories, Inc.
BIO · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Bio-Rad Laboratories, Inc.'s moat claims, evidence, and risks.
View BIO analysisManhattan Associates, Inc.
MANH · The Nasdaq Stock Market LLC
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Manhattan Associates, Inc.'s moat claims, evidence, and risks.
View MANH analysisComparison highlights
- Moat score gap: Bio-Rad Laboratories, Inc. leads (61 / 100 vs 56 / 100 for Manhattan Associates, Inc.).
- Segment focus: Bio-Rad Laboratories, Inc. has 2 segments (59.9% in Clinical Diagnostics); Manhattan Associates, Inc. has 4 segments (50.4% in Professional services (implementation, consulting, training)).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Weak.
- Moat breadth: Bio-Rad Laboratories, Inc. has 6 moat types across 3 domains; Manhattan Associates, Inc. has 7 across 1.
Primary market context
Bio-Rad Laboratories, Inc.
Clinical Diagnostics
In vitro diagnostics test systems, reagents/test kits, informatics, and clinical laboratory quality controls
Global
Hospital laboratories; diagnostic reference laboratories; transfusion laboratories; physician office laboratories
IVD OEM / installed-base consumables supplier (systems + kits + controls)
59.9%
Manhattan Associates, Inc.
Professional services (implementation, consulting, training)
Supply chain & omnichannel software implementation and consulting services
Global
Enterprises implementing or expanding supply chain/omnichannel systems
Implementation and advisory services provider
50.4%
Side-by-side metrics
Moat coverage
Shared moat types
Bio-Rad Laboratories, Inc. strengths
Manhattan Associates, Inc. strengths
Segment mix
Bio-Rad Laboratories, Inc. segments
Full profile >Life Science
Competitive
Clinical Diagnostics
Oligopoly
Manhattan Associates, Inc. segments
Full profile >Cloud subscriptions (Manhattan Active SaaS)
Oligopoly
Professional services (implementation, consulting, training)
Competitive
Maintenance and support (legacy perpetual licenses)
Monopoly
Perpetual licenses and hardware
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.